Matches in SemOpenAlex for { <https://semopenalex.org/work/W3147174823> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W3147174823 endingPage "769" @default.
- W3147174823 startingPage "759" @default.
- W3147174823 abstract "Onasemnogene Abeparvovec-xioi (AVXS-101) is a gene therapy intended for curative treatment of spinal muscular atrophy (SMA) with an expected price of around €2 000 000. The goal of this study is to perform a cost-effectiveness analysis of treatment of SMA I patients with AVXS-101 in The Netherlands including relapse scenarios.An individual-based state-transition model was used to model treatment effect and survival of SMA I patients treated with AVXS-101, nusinersen and best supportive care (BSC). The model included five health states: three health states according to SMA types, one for permanent ventilation and one for death. Deterministic and probabilistic sensitivity analyses were performed. Effects of relapsing to lower health states in the years following treatment was explored.The base-case incremental cost-effectiveness ratio (ICER) for AVXS-101 versus BSC is €138 875/QALY, and €53 447/QALY for AVXS-101 versus nusinersen. If patients relapse within 10 years after treatment with AVXS-101, the ICER can increase up to 6-fold, with effects diminishing thereafter. Only relapses occurring later than 50 years after treatment have a negligible effect on the ICER. To comply with Dutch willingness-to-pay reference values, the price of AVXS-101 must decrease to €680 000.Based on this model, treatment with AVXS-101 is unlikely to be cost-effective under Dutch willingness-to-pay reference values. Uncertainty regarding the long-term curative properties of AVXS-101 can result in multiplication of the ICER. Decision-makers are advised to appropriately balance these uncertainties against the price they are willing to pay now." @default.
- W3147174823 created "2021-04-13" @default.
- W3147174823 creator A5022725827 @default.
- W3147174823 creator A5026358497 @default.
- W3147174823 creator A5031404756 @default.
- W3147174823 creator A5035747289 @default.
- W3147174823 creator A5041722553 @default.
- W3147174823 creator A5049589704 @default.
- W3147174823 creator A5075745579 @default.
- W3147174823 date "2021-06-01" @default.
- W3147174823 modified "2023-10-18" @default.
- W3147174823 title "Early Cost-Effectiveness of Onasemnogene Abeparvovec-xioi (Zolgensma) and Nusinersen (Spinraza) Treatment for Spinal Muscular Atrophy I in The Netherlands With Relapse Scenarios" @default.
- W3147174823 cites W2063196635 @default.
- W3147174823 cites W2098529946 @default.
- W3147174823 cites W2103017827 @default.
- W3147174823 cites W2128911553 @default.
- W3147174823 cites W2346517606 @default.
- W3147174823 cites W2765253110 @default.
- W3147174823 cites W2765483614 @default.
- W3147174823 cites W2766093298 @default.
- W3147174823 cites W2774924171 @default.
- W3147174823 cites W2789114047 @default.
- W3147174823 cites W2795262817 @default.
- W3147174823 cites W2899450784 @default.
- W3147174823 cites W2904099718 @default.
- W3147174823 cites W2998050720 @default.
- W3147174823 doi "https://doi.org/10.1016/j.jval.2020.09.021" @default.
- W3147174823 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34119073" @default.
- W3147174823 hasPublicationYear "2021" @default.
- W3147174823 type Work @default.
- W3147174823 sameAs 3147174823 @default.
- W3147174823 citedByCount "19" @default.
- W3147174823 countsByYear W31471748232021 @default.
- W3147174823 countsByYear W31471748232022 @default.
- W3147174823 countsByYear W31471748232023 @default.
- W3147174823 crossrefType "journal-article" @default.
- W3147174823 hasAuthorship W3147174823A5022725827 @default.
- W3147174823 hasAuthorship W3147174823A5026358497 @default.
- W3147174823 hasAuthorship W3147174823A5031404756 @default.
- W3147174823 hasAuthorship W3147174823A5035747289 @default.
- W3147174823 hasAuthorship W3147174823A5041722553 @default.
- W3147174823 hasAuthorship W3147174823A5049589704 @default.
- W3147174823 hasAuthorship W3147174823A5075745579 @default.
- W3147174823 hasBestOaLocation W31471748231 @default.
- W3147174823 hasConcept C114614502 @default.
- W3147174823 hasConcept C126322002 @default.
- W3147174823 hasConcept C161921814 @default.
- W3147174823 hasConcept C1862650 @default.
- W3147174823 hasConcept C187212893 @default.
- W3147174823 hasConcept C2778558090 @default.
- W3147174823 hasConcept C2779134260 @default.
- W3147174823 hasConcept C2781172350 @default.
- W3147174823 hasConcept C33923547 @default.
- W3147174823 hasConcept C71924100 @default.
- W3147174823 hasConceptScore W3147174823C114614502 @default.
- W3147174823 hasConceptScore W3147174823C126322002 @default.
- W3147174823 hasConceptScore W3147174823C161921814 @default.
- W3147174823 hasConceptScore W3147174823C1862650 @default.
- W3147174823 hasConceptScore W3147174823C187212893 @default.
- W3147174823 hasConceptScore W3147174823C2778558090 @default.
- W3147174823 hasConceptScore W3147174823C2779134260 @default.
- W3147174823 hasConceptScore W3147174823C2781172350 @default.
- W3147174823 hasConceptScore W3147174823C33923547 @default.
- W3147174823 hasConceptScore W3147174823C71924100 @default.
- W3147174823 hasFunder F4320306202 @default.
- W3147174823 hasFunder F4320334661 @default.
- W3147174823 hasIssue "6" @default.
- W3147174823 hasLocation W31471748231 @default.
- W3147174823 hasLocation W31471748232 @default.
- W3147174823 hasLocation W31471748233 @default.
- W3147174823 hasLocation W31471748234 @default.
- W3147174823 hasOpenAccess W3147174823 @default.
- W3147174823 hasPrimaryLocation W31471748231 @default.
- W3147174823 hasRelatedWork W2002340042 @default.
- W3147174823 hasRelatedWork W2027120092 @default.
- W3147174823 hasRelatedWork W2059977016 @default.
- W3147174823 hasRelatedWork W2062455150 @default.
- W3147174823 hasRelatedWork W2153861281 @default.
- W3147174823 hasRelatedWork W2340526952 @default.
- W3147174823 hasRelatedWork W2471234061 @default.
- W3147174823 hasRelatedWork W2753594092 @default.
- W3147174823 hasRelatedWork W2888526297 @default.
- W3147174823 hasRelatedWork W4205452488 @default.
- W3147174823 hasVolume "24" @default.
- W3147174823 isParatext "false" @default.
- W3147174823 isRetracted "false" @default.
- W3147174823 magId "3147174823" @default.
- W3147174823 workType "article" @default.